USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
28 Jun 2021 | 02:30 PM GMT

Clinical & Economic outcomes from RPM (Remote Patient Monitoring)

Anchored by:

Don Deyo
Chief Executive Officer
LINDACARE
Elena Mustatea
CEO
BOLD HEALTH

Participants:

Don Deyo Chief Executive OfficerLindaCare
Don Deyo
Chief Executive OfficerLindaCare
Elena Mustatea CEOBold Health
Elena Mustatea
CEOBold Health
Armin Furtwaengler Global Medical Lead Innovation Scouting Boehringer Ingelheim International GmbH
Armin Furtwaengler
Global Medical Lead Innovation Scouting Boehringer Ingelheim International GmbH
Hiromasa Mori CNS Solution OwnerKoneksa
Hiromasa Mori
CNS Solution OwnerKoneksa
JM
john mattison CMIOACP
JM
john mattison
CMIOACP
Krys Zaluski Director, External GrowthBiogen
Krys Zaluski
Director, External GrowthBiogen
Liz Mosher Program Manager Sr. AssociateStanford Health Care
Liz Mosher
Program Manager Sr. AssociateStanford Health Care
Till Bauer Global Oncology LCM Strategy DirectorMSD
Till Bauer
Global Oncology LCM Strategy DirectorMSD
Todd Greenwood Sr. Director Evidence Generation and OutcomesZS Associates
Todd Greenwood
Sr. Director Evidence Generation and OutcomesZS Associates
Todd Greenwood Director Evidence GenerationZS Associates
Todd Greenwood
Director Evidence GenerationZS Associates

About this Meeting

What are the thresholds of evidence, both clinical and economic, required by digital products operating in the RPM space?  Do these thresholds vary by region/ jurisdiction, by clinical/ therapy area of operation, by stakeholder (hospital, payer, pharma, etc)? A survey from 2020 suggested that 55 to 58% of the European physicians believe that Remote Patient Monitoring (RPM) will play a key role in the future of care. But in order to successfully gain adoption, we need to understand the above. Join to have an informal conversation with other thought leaders on:  

  • Clinical outcomes: level of evidence needed, challenges to build meaningful and trustworthy clinical evidence, best practices and real examples.
  • Economic outcomes: how health systems and payers can leverage RPM solutions for disease prevention and management to ultimately reduce healthcare costs, and challenges digital health companies face to generate relevant evidence.